CoChat

High Amounts of S100-Alarmins Confer Antimicrobial Activity on Human Breast Milk Targeting Pathogens Relevant in Neonatal Sepsis

Open access
Pirr, Sabine, Richter, Manuela, Fehlhaber, Beate, Pagel, Julia, Härtel, Christoph, Roth, Johannes, Vogl, Thomas, Viemann, Dorothee · 2017 · Frontiers in Immunology
Cited by 38

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Sepsis is a leading cause of perinatal mortality worldwide. Breast milk feeding is protective against neonatal sepsis but the molecular mechanisms remain unexplained. Despite various supplementations with potential bioactive components from breast milk formula feeding cannot protect from sepsis. S100-alarmins are important immunoregulators in newborns preventing excessive inflammation. At high concentrations, the S100A8/A9 protein complex also has antimicrobial properties due to its metal ion chelation capacity. To assess whether breast milk contains S100-alarmins that might mediate the sepsis-protective effect of breast milk ninety-seven human breast milk samples stratified for gestational age, mode of delivery and sampling after birth were collected and analyzed. S100A8/A9 levels were massively elevated after birth (p < 0.0005). They slowly decreased during the first month of life, then reaching levels comparable to normal values in adult serum. The concentration of S100A8/A9 in breast milk was significantly higher after term compared to preterm birth (extremely preterm, p < 0.005; moderate preterm, p < 0.05) and after vaginal delivery compared to caesarean section (p < 0.0005). In newborn s100a9-/- mice, enterally supplied S100-alarmins could be retrieved systemically in the plasma. To explore the antimicrobial activity against common causal pathogens of neonatal sepsis purified S100-alarmins and unmodified as well as S100A8/A9-depleted breast milk were used in growth inhibition tests. The high amount of S100A8/A9 proved to be an important mediator of the antimicrobial activity of breast milk, especially inhibiting the growth of manganese sensitive bacteria like Staphylococcus aureus (p < 0.00005) and group B streptococci (p < 0.005). Depletion of S100A8/A9 significantly reduced this effect (p < 0.05, respectively). The growth of Escherichia coli was also inhibited by breast milk (p < 0.00005) as well as by S100A8/A9 in culture assays (p < 0.05). But its growth in breast milk remained unaffected by the removal of S100A8/A9 and was neither dependent on manganese suggesting that the antimicrobial effects of S100A8/A9 in breast milk are primarily mediated by its manganese chelating capacity. In summary, the enteral supply of bioavailable, antimicrobially active amounts of S100-alarmins might be a promising option to protect newborns at high risk from infections and sepsis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2017.01822

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 38

Metadata

Authors
Pirr, S., Richter, M., Fehlhaber, B., Pagel, J., Härtel, C., Roth, J., Vogl, T., & Viemann, D.
Venue
Frontiers in Immunology
Published
2017-12-13
Volume
8
Pages
1822-1822
ISSN
1664-3224 (ISSN-L)
OpenAlex
W2771510728
Cited by
38
References
6
FWCI
1.89
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High Amounts of S100-Alarmins Confer Antimicrobial Activity on Human Breast Milk Targeting Pathogens Relevant in Neonatal Sepsis. https://app.cochat.ai/papers/10.3389/fimmu.2017.01822
The paper
Pirr, S., Richter, M., Fehlhaber, B., Pagel, J., Härtel, C., Roth, J., Vogl, T., & Viemann, D. (2017). High Amounts of S100-Alarmins Confer Antimicrobial Activity on Human Breast Milk Targeting Pathogens Relevant in Neonatal Sepsis. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2017.01822

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.